In the present study, we found significantly higher DDX21 protein expression in recurrent HCC patients than in nonrecurrent cases, and elevated DDX21 protein levels were correlated with decreased recurrence-free survival in HCC patients. This evidence concerns the gene DDX21 and hepatocellular carcinoma.